Physician profile
Mark Benjamin
NPI 1992760185
$6,578.83
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $970 · 2020: $905 · 2021: $864 · 2022: $1,262 · 2023: $1,440 · 2024: $1,138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,488 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,487.79 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,951.43 | 2019-2024 | Breztri, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $1,505.86 | 2019-2024 | Trelegy Ellipta, Nucala |
| Jazz Pharmaceuticals INC. | $565.43 | 2019-2024 | Xywav |
| Harmony Biosciences LLC | $391.86 | 2021-2024 | Wakix |
| Genzyme Corporation | $313.76 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $305.06 | 2019-2022 | |
| Amgen INC. | $124.69 | 2021-2024 | Tezspire |
| Advanced Respiratory, INC | $62.31 | 2019 | |
| Mylan Specialty L.P. | $59.16 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $58.41 | 2022-2024 | Dupixent |
| Avadel Cns Pharmaceuticals, LLC | $53.52 | 2024 | Lumryz |
| Abbott Laboratories | $41.31 | 2019 | |
| Novartis Pharmaceuticals Corporation | $32.59 | 2019-2023 | |
| Philips North America LLC | $26.56 | 2022 | |
| Sanofi-Aventis U.S. LLC | $22.10 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $22.07 | 2019 | |
| Genentech USA, INC. | $15.50 | 2021 | |
| Mallinckrodt Hospital Products INC. | $13.92 | 2022 | |
| Merck Sharp & Dohme LLC | $13.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Benjamin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.